Evidence map›Paper›PMID 27488633›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2016

Noninvasive Evaluation of Cellular Proliferative Activity in Brain Neurogenic Regions in Rats under Depression and Treatment by Enhanced [18F]FLT-PET Imaging.

Yasuhisa Tamura, Kayo Takahashi, Kumi Takata, Asami Eguchi, Masanori Yamato, Satoshi Kume, Masayuki Nakano, Yasuyoshi Watanabe, Yosky Kataoka

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. PET imaging of animal models with depressive-like phenotypes.European journal of nuclear medicine and molecular imaging · 2023
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Adult Hippocampal Neurogenesis: A Coming-of-Age Story.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yasuhisa TamuraCellular Function Imaging Team, Multi-Modal Microstructure Analysis Unit, and tamuray@riken.jp.
Kayo TakahashiPathophysiological and Health Science Team, Center for Life Science Technologies, RIKEN, Kobe 650-0047, Japan.
Kumi TakataCellular Function Imaging Team.
Asami EguchiCellular Function Imaging Team.
Masanori YamatoCellular Function Imaging Team, Multi-Modal Microstructure Analysis Unit, and.
Satoshi KumeCellular Function Imaging Team, Multi-Modal Microstructure Analysis Unit, and.
Masayuki NakanoCellular Function Imaging Team.
Yasuyoshi WatanabePathophysiological and Health Science Team, Center for Life Science Technologies, RIKEN, Kobe 650-0047, Japan.
Yosky KataokaCellular Function Imaging Team, Multi-Modal Microstructure Analysis Unit, and.ORCID 0000-0002-6658-4163
CE Technologies (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledNeural stem cells in two neurogenic regions, the subventricular zone and the subgranular zone (SGZ) of the hippocampal dentate gyrus, can divide and produce new neurons throughout life. Hippocampal neurogenesis is related to emotions, including depression/anxiety, and the therapeutic effects of antidepressants, as well as learning and memory. The establishment of in vivo imaging for proliferative activity of neural stem cells in the SGZ might be used to diagnose depression and to monitor the therapeutic efficacy of antidepressants. Positron emission tomography (PET) imaging with 3'-deoxy-3'-[(18)F]fluoro-l-thymidine ([(18)F]FLT) has been studied to allow visualization of proliferative activity in two neurogenic regions of adult mammals; however, the PET imaging has not been widely used because of lower accumulation of [(18)F]FLT, which does not allow quantitative assessment of the decline in cellular proliferative activity in the SGZ under the condition of depression. We report the establishment of an enhanced PET imaging method with [(18)F]FLT combined with probenecid, an inhibitor of drug transporters at the blood-brain barrier, which can allow the quantitative visualization of neurogenic activity in rats. Enhanced PET imaging allowed us to evaluate reduced cell proliferation in the SGZ of rats with corticosterone-induced depression, and further the recovery of proliferative activity in rats under treatment with antidepressants. This enhanced [(18)F]FLT-PET imaging technique with probenecid can be used to assess the dynamic alteration of neurogenic activity in the adult mammalian brain and may also provide a means for objective diagnosis of depression and monitoring of the therapeutic effect of antidepressant treatment. SIGNIFICANCE STATEMENT: Adult hippocampal neurogenesis may play a role in major depression and antidepressant therapy. Establishment of in vivo imaging for hippocampal neurogenic activity may be useful to diagnose depression and monitor the therapeutic efficacy of antidepressants. Positron emission tomography (PET) imaging has been studied to allow visualization of neurogenic activity; however, PET imaging has not been widely used due to the lower accumulation of the PET tracer in the neurogenic regions. Here, we succeeded in establishing highly quantitative PET imaging for neurogenic activity in adult brain with an inhibitor for drug transporter. This enhanced PET imaging allowed evaluation of the decline of neurogenic activity in the hippocampus of rats with depression and the recovery of neurogenic activity by antidepressant treatment.

Indexed as

AnimalsAntidepressive AgentsBrainCell ProliferationDepressionDideoxynucleosidesImage EnhancementMaleNeurogenesisNeuronsPositron-Emission TomographyRadiopharmaceuticalsRatsRats, WistarReproducibility of ResultsSensitivity and SpecificityalovudineAntidepressive AgentsDideoxynucleosidesRadiopharmaceuticalsdepressiondrug transportersneurogenesisPET imagingSSRI

Identifiers

PMID27488633
PMCPMC6601957
OpenAlexW2500435521

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.